Respiratory Tract Diseases

568 trials 207 recruiting

Filter these 568 trials by phase, country and sponsor.

Open in Search →

Shorter weaning from invasive ventilation with levosimendan: a randomized, double-blind, multicenter study in critically ill patients. Recruiting

2024-518810-23-00 Failure to wean from invasive ventilation. 6 2025-09-17
A study to test Inhaled Molgramostim in Pediatric Participants with Autoimmune Pulmonary Alveolar Proteinosis (aPAP) Recruiting

2024-512039-66-00 Autoimmune pulmonary alveolar proteinosis 5 2025-09-11
High Dose Dexamethasone to Reduce Acute Postoperative Pain Following Video-Assisted Thoracoscopic Surgery Lobectomy and Segmentectomy Recruiting

2025-520891-25-00 Lung cancer 4 2025-08-28
TOCIACS : Efficacy and safety of Tocilizumab for acute chest syndrome treatment in paediatric and adult patients with sickle cell disease Recruiting

2023-505109-17-00 Sickle cell disease 5 2025-08-27
Perioperative Inhaled Therapy in Carcinological Thoracic Surgery in patients at high risk of postoperative pulmonary complications Recruiting

2023-510564-12-00 postoperative pulmonary complications 5 2025-08-14
Senicapoc in patients with progressive fibrotic interstitial lung disease Recruiting

2024-511131-97-00 Progressive Fibrotic Interstitial Lung Disease 4 2025-08-10
RANDOMIZED, DOUBLE BLIND, PLACEBO CONTROLLED, TWO-ARMS, MULTICENTER, POST AUTHORIZATION EFFICACY AND SAFETY STUDY (PAES) TO CONFIRM AND COLL… Recruiting

2024-512937-34-00 RECURRENT LOWER RESPIRATORY TRACT INFECTIONS (RLRTIS). 6 2025-08-06
A Randomized, Double-Blind, Placebo-Controlled Trial on Efficacy and Safety of Fluticasone Propionate/Albuterol Sulfate Combination in Parti… Recruiting

2024-517991-39-00 Asthma 5 2025-07-22
Sacituzumab govitecan (SG) with bevacizumab for the treatment of brain metastases from non-small cell lung cancer (NSCLC) Recruiting

2024-514066-40-00 Patients with metastatic non-squamous NSCLC pre-treated 4 2025-07-10
An Open-Label Extension Study of Subjects who Received an Avalyn Inhaled Antifibrotic Agent Recruiting

2024-518289-28-00 Progressive pulmonary fibrosis [PPF] Idiopathic pulmon 4 2025-07-04
Safety and clinical parameter assessment of self-infusion therapy with Prolastin® in patients with severe AATD Recruiting

2024-515894-80-00 Severe Alpha-1 Antitrypsin Deficiency (AATD) 5 2025-07-01
Phase 1, Randomized, Double-blind, Placebo-Controlled, First-in-Human Single Ascending Dose Study in Healthy Participants to Assess the Safe… Recruiting

2024-517644-62-00 Mild to Moderate Asthma 1 2025-06-30
Efficacy of methylprednisolone pulses in neuroendocrine cells hyperplasia of infancy: an early phase study (CORTICONEHI). Recruiting

2023-508132-65-00 NEUROENDOCRINE CELLS HYPERPLASIA OF INFANCY 4 2025-06-30
Tezepelumab (Anti-TSLP-mab) in progressive pulmonary fibrosis interstitial lung disease with evidence of eosinophilia - A prospective two-ar… Recruiting

2024-510884-51-00 Progressive pulmonary fibrosis interstitial lung diseas 4 2025-06-09
A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants with Moderate to Very Severe Chronic Obstructive Pulmona… Recruiting

2024-517458-90-00 Chronic obstructive pulmonary disease (COPD) 5 2025-06-06
A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants with Moderate to Very Severe Chronic Obstructive Pulmona… Recruiting

2024-517457-27-00 Chronic Obstructive Pulmonary Disease (COPD) 5 2025-06-04
PsyPal; Psilocybin Therapy for Psychological Distress in Palliative Patients Recruiting

2023-510488-36-01 Chronic obstructive pulmonary disease (COPD), amyotroph 4 2025-06-01
Dose Range Finding Study to Access Efficacy and Safety of Tozorakimab in Adults with Uncontrolled Asthma on Medium-to-High Dose Inhaled Cort… Recruiting

2024-519116-14-00 Asthma 4 2025-05-27
A Phase 1 Study Evaluating the Safety, Tolerability, and Efficacy of BL-B01D1 in Subjects with Metastatic or Unresectable Non-Small Cell Lun… Recruiting

2023-506539-14-00 Oncology 3 2025-05-27
Study of lunsekimig (SAR443765) compared with placebo in adults with high-risk asthma Recruiting

2024-513959-33-00 Asthma 4 2025-05-13
A study to evaluate the benefit of adding durvalumab after chemotherapy, durvalumab and surgery in patients with early-stage, operable, non-… Recruiting

2023-508773-82-00 Stage IIB-IIIB (N2) resectable non small cell lung canc 5 2025-05-06
FESSnonFESS Recruiting

2024-514632-24-02 Chronic Rhinosinusitis with Nasal Polyposis 11 2025-05-02
A trial to learn how well benralizumab works and how safe it is when given in addition to standard asthma treatments in people with eosinoph… Recruiting

2024-515162-13-00 Eosinophilic Asthma 5 2025-04-29
Non-Invasive Ventilation versus High Flow Oxygenotherapy in Patients at High Risk of Extubation Failure Recruiting

2024-514640-81-00 Weaning of Mechanical ventilation 6 2025-04-23